Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 18, Issue 2

March-April 2021

Issue PDF

In this Issue

Ask the Hematologist
Clinical Trials Corner
Diffusion
Features
Headlines from Washington
President’s Column

Ask the Hematologist

Practical Issues in Lymphoma Care During the COVID-19 Pandemic

Lisa K. Hicks, MD, MSc, FRCPC,Abi Vijenthira, MD, FRCPC

View Articletitled, Practical Issues in Lymphoma Care During the COVID-19 Pandemic

Clinical Trials Corner

Rallying Macrophages in the Fight Against MDS and AML

Andrew A. Guirguis, MBBS, PhD, FRACP, FRCPA,Steven Lane, MBBS, PhD, FRACP, FRCPA

View Articletitled, Rallying Macrophages in the Fight Against MDS and AML

Pursuing a Chemotherapy-free Regimen in Philadelphia Chromosome-Positive ALL

Kristen M. O’Dwyer, MD

View Articletitled, Pursuing a Chemotherapy-free Regimen in Philadelphia Chromosome-Positive ALL

Diffusion

Expanding the Use of Rivaroxaban for Patients With Atrial Fibrillation: The RIVER Trial

Eric Tseng, MD, MScCH, FRCPC

View Articletitled, Expanding the Use of Rivaroxaban for Patients With Atrial Fibrillation: The RIVER Trial

Assessing the Gravidy of Direct Oral Anticoagulants in Pregnancy

Damon Houghton, MD,Ariela L. Marshall, MD

View Articletitled, Assessing the <em>Gravidy</em> of Direct Oral Anticoagulants in Pregnancy

Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors

Amy DeZern, MD, MHS

View Articletitled, Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors

Battle of the Proteasome Inhibitors: Which One Endured?

Saad Usmani, MD, MBA, FACP

View Articletitled, Battle of the Proteasome Inhibitors: Which One Endured?

Immunotherapy and TKIs: Precision Agonism or Antagonism for Ph+ ALL?

Sarah K. Tasian, MD

View Articletitled, Immunotherapy and TKIs: Precision Agonism or Antagonism for Ph+ ALL?

A Predictive Biomarker in Lymphoma: Better Late Than Never

Brad Kahl, MD

View Articletitled, A Predictive Biomarker in Lymphoma: Better Late Than Never

Building a Model of Myelodysplastic Syndromes From the Ground Up

Robert P. Hasserjian, MD

View Articletitled, Building a Model of Myelodysplastic Syndromes From the Ground Up

A World of Pain: How Past Violent/Painful Experiences Predict Present Chronic Pain and Daily Opioid Use in Adults With Sickle Cell Disease

Carolyn Chen, BA,Ifeyinwa (Ify) Osunkwo, MD, MPH

View Articletitled, A World of Pain: How Past Violent/Painful Experiences Predict Present Chronic Pain and Daily Opioid Use in Adults With Sickle Cell Disease

Features

Update on the Cure Sickle Cell Initiative

Leslie E. Silberstein, MD,Marilyn J. Telen, MD

View Articletitled, Update on the Cure Sickle Cell Initiative

A Look Into ASH’s Diversity, Equity, and Inclusion Efforts

Christopher R. Flowers, MD, MS,Chancellor E. Donald, MD

View Articletitled, A Look Into ASH’s Diversity, Equity, and Inclusion Efforts

Headlines from Washington

ASH Celebrates Advocacy Victories and Looks Toward the Future

ASH Staff

View Articletitled, ASH Celebrates Advocacy Victories and Looks Toward the Future

President’s Column

ASH’s Global Reach

Martin S. Tallman, MD

View Articletitled, ASH’s Global Reach

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Ask the Hematologist

Practical Issues in Lymphoma Care During the COVID-19 Pandemic

Clinical Trials Corner

Rallying Macrophages in the Fight Against MDS and AML

Pursuing a Chemotherapy-free Regimen in Philadelphia Chromosome-Positive ALL

Diffusion

Expanding the Use of Rivaroxaban for Patients With Atrial Fibrillation: The RIVER Trial

Assessing the Gravidy of Direct Oral Anticoagulants in Pregnancy

Short-term Gain But Long-term Pain? Clonal Hematopoiesis and the Risk of Therapy-related Myeloid Neoplasms After Treatment for Solid Tumors

Battle of the Proteasome Inhibitors: Which One Endured?

Immunotherapy and TKIs: Precision Agonism or Antagonism for Ph+ ALL?

A Predictive Biomarker in Lymphoma: Better Late Than Never

Building a Model of Myelodysplastic Syndromes From the Ground Up

A World of Pain: How Past Violent/Painful Experiences Predict Present Chronic Pain and Daily Opioid Use in Adults With Sickle Cell Disease

Features

Update on the Cure Sickle Cell Initiative

A Look Into ASH’s Diversity, Equity, and Inclusion Efforts

Headlines from Washington

ASH Celebrates Advocacy Victories and Looks Toward the Future

President’s Column

ASH’s Global Reach

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Ask the Hematologist

Clinical Trials Corner

Diffusion

Features

Headlines from Washington

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only